Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:277-278 (4 February), doi:10.1136/bmj.332.7536.277-a
Paul Haber, head of department of drug and alcohol services1
1 Royal Prince Alfred Hospital, NSW 2050, Australia phaber@mail.usyd.edu.au
| The first 150 words of the full text of this article appear below. |
Mr Bond's management raises several issues.1 In the rapid responses on bmj.com, Mark Willenbring succinctly summarises the most practical approach to the management of Mr Bond's alcohol dependence.2 Regular follow-up with feedback on progress and continuing encouragement to reduce alcohol use can be surprisingly effective. It is also a straightforward management plan that can be offered by the patient's current medical team. Cirrhotic patients can safely be offered treatment to control their alcohol use with acamprosate, naltrexone, or disulfiram, singly or in combination.3 These drugs are simpler to prescribe and monitor than many used in routine clinical practice and do not have to be given by addiction specialists. Colin Brewer correctly notes that the oldest of these, disulfiram, may be the most effective if administration is supervised by a community nurse or family member.2 However, unsupervised disulfiram is ineffective.
Is there any specific medical therapy for progressive alcoholic liver
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?